Global 500

Rank
470
Previous: 469 Next: 471

AstraZeneca

Life Science Nord presents industry data
Pills lying in a packaging machine at pharmaceuticals manufacturer AstraZeneca in Wedel, Germany, 31 October 2016. The industrial health industry plays an important role in Hamburg and Schleswig-Holstein. According to a new study of research institute Wifor, the industry has grown by 1.3 percent since 2004. Photo by: Daniel Bockwoldt/picture-alliance/dpa/AP ImagesDaniel Bockwoldt — picture-alliance/AP
  • Previous Rank
    435
  • Revenues ($M)
    23002
  • Revenue Percent Change
    -6.9
  • Profits ($M)
    3499
  • Profits Percent Change
    23.9
  • Assets ($M)
    62526
  • Employees
    59700

Company Information

CEOPascal Soriot
SectorHealth Care
IndustryPharmaceuticals
HQ LocationCambridge, Britain
Websitewww.astrazeneca.com
Years on Global 500 List19
Employees59,700

Key Financials (Last Fiscal Year)

Revenues ($M)$23,002
Profits ($M)$3,499
Assets ($M)$62,526
Total Stockholder Equity ($M)$14,854

Profit Ratios

Profit as % of Revenues15.2%
Profits as % of Assets5.6%
Profits as % of Stockholder Equity23.6%